On the 20th, the KOSPI index showed a slight upward trend in the early session. With the approach of the inauguration of Trump’s second administration, investors seem to be growing cautious.
As of 9:07 a.m. that day, the KOSPI index recorded 2,530.29, up 6.74 points (0.27%).
In the stock exchange market, individuals are net buying shares worth 79.9 billion won, while foreigners and institutions are net selling shares worth 72.7 billion won and 6.6 billion won, respectively.
Among the top market cap stocks, SK Hynix, LG Energy Solution, Samsung Biologics, Shinhan Financial Group, and POSCO Holdings are rising, whereas Samsung Electronics, Hyundai Motor, Kia, Celltrion, KB Financial Group, Naver, and HD Hyundai Heavy Industries are declining.
SK Bioscience is experiencing an 8% surge following the news of obtaining approval for a phase 3 clinical trial of its pneumococcal vaccine in the United States. Geumyang is showing a 7% rise due to the cancellation of a 450 billion won shareholder allocation capital increase, and Korea Zinc is also rising in anticipation of an extraordinary general meeting of shareholders on the 23rd.
At the same time, the KOSDAQ index is recording 727.58, up 2.89 points (0.4%) from the previous trading day.
In the KOSDAQ market, individuals are net buying shares worth 22.6 billion won, while foreigners and institutions are net selling shares worth 21.0 billion won and 1.8 billion won, respectively.
Among the top KOSDAQ stocks by market capitalization, Alteogen, Ecopro BM, HLB, Ecopro, Rainbow Robotics, and Enchem are rising, while Rigem Bio, Samjin Pharmaceutical, Classys, Hugel, Leeno Industrial, and PharmaResearch are declining.
In the Seoul foreign exchange market, the won-dollar exchange rate opened at 1,460 won, up 1.7 won from the previous day.